Fabrication of a conductive, ionic liquid functionalized, oxygen-generating hydrogel loaded with ADSC-derived exosomes to enhance angiogenesis and cardiac repair after acute myocardial infarction.
Xu Z., Chen J., Shu L., Hong W., Mo Y., Wang J.
Animal Study on Cardiovascular Disease, Scar, published in Theranostics (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Theranostics (2026)
- Country
- Australia
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41356188
- DOI
- 10.7150/thno.118652
Abstract (original English)
Acute myocardial infarction (AMI) remains one of the most severe and life-threatening cardiac diseases, accounting for a substantial proportion of mortality worldwide and necessitating the development of novel treatment approaches for effective myocardial repair. Biocompatible, ionically conductive injectable hydrogel scaffolds have emerged as promising candidates for AMI treatment owing to their prominent electrical conductivity and mechanical compatibility with cardiac tissue. Methods: In the present investigation, a facile ionic-conductive injectable hydrogel was developed by incorporating the conductive polymer PEDOT and boronic acid-functionalized carboxymethyl chitosan (pCMC) with poly-ionic liquid (P-ILs), oxygen-generating calcium peroxide (CaO 2 ) particles, and adipose-derived stem cell exosomes (ADSC-exos) to improve myocardial regeneration via enhancing conductivity and oxygen release. The physiological and mechanical characteristics of the injectable hydrogel were examined through morphological evaluation, oxygen-release profiling, electroactivity, and rheological analysis. In vitro biocompatibility was assessed using rat cardiac fibroblasts (RCF) and H9C2 cells. For in vivo investigation, a rat ischemia-reperfusion model was established, and the developed hydrogels were administered for 28 days to examine cardiac function recovery and myocardial regeneration. Resu
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Factor XII-A New Therapeutic Target? A Systematic Review
Systematic Review on Cardiovascular Disease, Neuroinflammation, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci1 citations - Level AMeta-analysisEurope PMC
Can cell-based therapies bridge the gap between research and reality in the treatment of myocarditis? A systematic review and meta-analysis
Meta-analysis on Cardiovascular Disease, published in Regen Ther (2026) — summary generated from the PubMed abstract.
- 2026
Regen Ther - Level AMeta-analysisEurope PMC
Efficacy and safety of stem cell therapy for myocardial infarction and heart failure: an updated systematic review and meta-analysis of randomized controlled trials
Meta-analysis with a reported sample of 3345 on Cardiovascular Disease, Stroke Research, published in Syst Rev (2026) — summary generated from the PubMed abstract.
- 2026
- n = 3345
Syst Rev - Level AMeta-analysisEurope PMC
Orally derived mesenchymal stem cells in the treatment of vascular diseases: a systematic review and meta-analysis
Meta-analysis on Cardiovascular Disease, published in Sci Rep (2026) — summary generated from the PubMed abstract.
- 2026
Sci Rep - Level ASystematic ReviewEurope PMC
From Preservation to Repair: A Systematic Review of Therapeutic Organ Rehabilitation During Normothermic Ex Vivo Machine Perfusion
Systematic Review with a reported sample of 12 on Cardiovascular Disease, Immune Modulation, published in Transplant Direct (2026) — summary generated from the PubMed abstract.
- 2026
- n = 12
Transplant Direct - Level AMeta-analysisEurope PMC
Safety and Efficacy of Transendocardial Stem Cells Therapy in Chronic Ischemic Heart Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Meta-analysis on Cardiovascular Disease, Stroke Research, published in Curr Cardiol Rev (2025) — summary generated from the PubMed abstract.
- 2025
Curr Cardiol Rev